<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE QUARTERLY FINANCIAL STATEMENTS OF INHALE THERAPEUTIC SYSTEMS, INC. AS FILED ON FORM 10Q FOR THE PERIOD ENDED MARCH 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <MULTIPLIER> 1,000 <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-1999 <PERIOD-START> JAN-01-1999 <PERIOD-END> MAR-31-1999 <CASH> 18,023 <SECURITIES> 55,553 <RECEIVABLES> 2,435 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 76,807 <PP&E> 64,201 <DEPRECIATION> (9,752) <TOTAL-ASSETS> 131,349 <CURRENT-LIABILITIES> 14,657 <BONDS> 4,925 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 172,920 <OTHER-SE> (62,142) <TOTAL-LIABILITY-AND-EQUITY> 131,349 <SALES> 0 <TOTAL-REVENUES> 7,780 <CGS> 0 <TOTAL-COSTS> 13,980 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (5,223) <INCOME-TAX> 0 <INCOME-CONTINUING> 0 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (5,223) <EPS-PRIMARY> (0.31) <EPS-DILUTED> (0.31)